Medications starting with
Poland-
The medicine is used to treat heart failure to prevent the disease from worsening and to reduce the number of hospitalizations. It is used in people who have had a heart attack (in combination with other medicines) or when mild symptoms persist despite previous treatment.
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC code: C03DA04
Manufacturer: Iasis Pharmaceuticals Hellas S.A.-Koropi
-
The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations, especially in people following a recent heart attack or in patients with persistent, mild symptoms despite current treatment.
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC code: C03DA04
Manufacturer: Medis International a.s.
-
The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations. It is intended for individuals who have recently suffered a heart attack or for patients with persistent, mild symptoms of heart failure.
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC code: C03DA04
Manufacturer: Medis International a.s.
-
The medicine is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin hydrochloride 850 mg ATC code: A10BD07
Manufacturer: Lek d.d., PE PROIZVODNJA LENDAVA Lek S.A.
-
The medicine is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin hydrochloride 1000 mg ATC code: A10BD07
Manufacturer: Lek d.d., PE PROIZVODNJA LENDAVA Lek S.A.
-
The medicine is used to reduce the body's immune response. In patients following organ, bone marrow, or stem cell transplants, it prevents transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.
Dosage form: capsules, soft gelatin
Active substance Dosage ciclosporin 25 mg ATC code: L04AD01
Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.
-
The medicine is used to reduce the body's immune response. It helps prevent the rejection of transplanted organs, bone marrow, or stem cells, and is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, or nephrotic syndrome.
Dosage form: capsules, soft gelatin
Active substance Dosage ciclosporin 50 mg ATC code: L04AD01
Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.
-
The medicine is used to reduce the body's immune response. In patients following organ, bone marrow, or stem cell transplants, it prevents transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.
Dosage form: capsules, soft gelatin
Active substance Dosage ciclosporin 100 mg ATC code: L04AD01
Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.
-
The medicine is used in patients after an organ, bone marrow, or stem cell transplant to prevent transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe cases of atopic dermatitis, psoriasis, rheumatoid arthritis, and nephrotic syndrome.
Dosage form: solution, oral
Active substance Dosage ciclosporin 100 mg/ml ATC code: L04AD01
Manufacturer: Teva Pharma - Produtos Farmacêuticos, Ltd.
-
The medicine is used to treat early symptoms of recurrent herpes labialis in adults and children over 12 years of age.
Dosage form: cream
Active substance Dosage doconazole 100 mg ATC code: D06BB11
Manufacturer: Laboratori Fundació Dau
-
The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.
Dosage form: powder for preparation of oral suspension
Active substance Dosage erdosteine 35 mg/ml ATC code: R05CB15
Manufacturer: Fulton Medicinali S.p.A. Zeta Farmaceutici S.p.A.
-
The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.
Dosage form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC code: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
It is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It may also be used preventatively during seasonal exacerbations of chronic bronchitis.
Dosage form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC code: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.
Dosage form: capsules, hard
Active substance Dosage erdosteine 300 mg ATC code: R05CB15
Manufacturer: Angelini Pharma Czech Republic s.r.o.
-
The medicine is used to thin and facilitate the expectoration of mucus from the respiratory tract. It is used as support in the treatment of inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.
Dosage form: powder for preparation of oral suspension
Active substance Dosage erdosteine 225 mg ATC code: R05CB15
Manufacturer: Fine Food & Pharmaceuticals NTM S.P.A.
-
The medicine is used to facilitate expectoration and reduce the viscosity of secretions in acute and chronic diseases of the respiratory tract, bronchi, and lungs. It also helps in preventing seasonal exacerbations of chronic bronchitis.
Dosage form: powder for preparation of oral suspension
Active substance Dosage erdosteine 35 mg/ml ATC code: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.
Dosage form: tablets
Active substance Dosage erdosteine 300 mg ATC code: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine helps to thin and facilitate the expectoration of mucous secretion from the respiratory tract. It is used as support in the treatment of acute and chronic inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.
Dosage form: tablets
Active substance Dosage erdosteine 225 mg ATC code: R05CB15
Manufacturer: Mako Pharma Sp. z o.o.
-
It is used to treat fungal skin infections (e.g., groin, feet, or hairy scalp) and nail fungus caused by dermatophytes. However, it is not effective in treating pityriasis versicolor.
Dosage form: tablets
Active substance Dosage terbinafine hydrochloride 281.3 mg ATC code: D01BA02
Manufacturer: Polfarmex S.A.
-
The medicine is used to prevent and treat vascular headaches, including migraine headaches and cluster headaches.
Dosage form: tablets, coated
Active substance Dosage ergotamine tartrate 1 mg ATC code: N02CA
Manufacturer: Pharmaceutical Workers' Cooperative FILOFARM
-
The medicine is intended for adults with advanced breast cancer or metastatic breast cancer (after other therapies have ceased to be effective). It is also used in the treatment of advanced liposarcoma or metastatic liposarcoma, when other treatment methods have proven ineffective.
Dosage form: solution for injection
Active substance Dosage eribulin 0.44 mg/ml ATC code: L01XX41
Manufacturer: EVER Pharma Jena GmbH Oncomed manufacturing a.s.
-
The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation) and for the treatment and prevention of recurrence of clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.
Dosage form: capsules, hard
Active substance Dosage apixaban 5 mg ATC code: B01AF02
Manufacturer: Adamed Pharma S.A.
-
Erimpox is used in adults to prevent the formation of blood clots after hip or knee surgery and in people with an irregular heartbeat (atrial fibrillation) to prevent stroke. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.
Dosage form: capsules, hard
Active substance Dosage apixaban 2.5 mg ATC code: B01AF02
Manufacturer: Adamed Pharma S.A.
-
It is intended for adult men with erectile dysfunction. It helps improve the ability to achieve an erection sufficient for sexual intercourse.
Dosage form: tablets, film-coated
Active substance Dosage tadalafil 2.5 mg ATC code: G04BE08
-
The medicine is used in adult men to treat erectile dysfunction and to relieve symptoms associated with benign prostatic hyperplasia (such as difficulty urinating or frequent urination).
Dosage form: tablets, film-coated
Active substance Dosage tadalafil 5 mg ATC code: G04BE08
-
The medicine is intended for adult men with erectile dysfunction. It helps to achieve and maintain an erection necessary for sexual intercourse, but it only works when sexual stimulation is present.
Dosage form: tablets, film-coated
Active substance Dosage tadalafil 10 mg ATC code: G04BE08
-
The medicine is intended for adult men with erectile dysfunction, a condition in which a man is unable to achieve or maintain an erection sufficient for sexual intercourse.
Dosage form: tablets, film-coated
Active substance Dosage tadalafil 20 mg ATC code: G04BE08
-
The medicinal product is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27.32 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
The medicinal product is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided that specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 109.27 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
The medicinal product is used in adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided that specific EGFR mutations are present) and in patients with metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163.9 mg ATC code: L01EB02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (provided specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01XE03
Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.
-
The medicinal product is used in adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) and in patients with metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01XE03
Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.
-
The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (depending on the cancer cell mutations) and for the treatment of metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01XE03
Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.
-
The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (when the cancer cells have specific EGFR mutations) and in the treatment of metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (when the cancer cells have specific EGFR mutations) or in cases where previous chemotherapy has not been effective. It may also be used in the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (provided specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy) and in the case of metastatic pancreatic cancer (used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicinal product is used in adult patients with advanced non-small cell lung cancer and in patients with metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01EB02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used to treat abdominal infections, lung infections (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections at the surgical site following procedures on the colon or rectum.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage ertapenem 1 g ATC code: J01DH03
Manufacturer: ACS Dobfar S.p.A.
-
The medicine is used to treat infections of the abdominal cavity, lungs (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections of the surgical site following procedures on the colon or rectum in adults.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage ertapenem sodium 1046 mg ATC code: J01DH03
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.
-
The medicinal product is an antibiotic used to treat infections of the abdomen, lungs (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections of the surgical site following procedures on the colon or rectum.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage ertapenem sodium No input provided ATC code: J01DH03
Manufacturer: ACS Dobfar S.p.A.
-
The medicine is intended for the treatment of erectile dysfunction (impotence) in adult men. It helps to achieve or maintain an erection, but it only works when sexual arousal has occurred.
Dosage form: tablets, film-coated
Active substance Dosage sildenafil citrate 35.125 mg ATC code: G04BE03
Manufacturer: Adamed Pharma S.A.
-
The medicine is intended for adult men to treat erectile dysfunction (impotence), which is the difficulty in achieving or maintaining an erection sufficient for sexual intercourse.
Dosage form: tablets, film-coated
Active substance Dosage sildenafil citrate 70.25 mg ATC code: G04BE03
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to treat blood cancer, mainly in children with acute lymphoblastic leukemia who have had an allergic reaction to other similar medicines. It is used in conjunction with other treatment methods.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage crisantaspase 10000 IU ATC code: L01XX02
Manufacturer: Almac Pharma Services Limited
-
This medicine is used to treat severe infections caused by susceptible microorganisms when it is necessary to rapidly achieve high drug concentrations in the blood or when oral administration is not possible. It is used, among others, in respiratory tract, ear, skin, soft tissue, and gastrointestinal tract infections, as well as in cases of sepsis or endocarditis.
Dosage form: solution for infusion, powder for preparation of
Active substance Dosage erythromycin 300 mg ATC code: J01FA01
Manufacturer: Fisiopharma S.r.L. Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
This medicine is used to treat infections caused by bacteria sensitive to erythromycin. It may be used, among others, for upper and lower respiratory tract infections (e.g., pharyngitis, pneumonia, sinusitis), ear, skin, and soft tissue infections, gastrointestinal tract infections, as well as for gonorrhea, syphilis, or diphtheria.
Dosage form: tablets, film-coated
Active substance Dosage erythromycin No input provided ATC code: J01FA01
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used as an emergency contraception method in urgent situations, such as unprotected sexual intercourse or the failure of a current contraceptive method (e.g., a broken condom).
Dosage form: tablets
Active substance Dosage levonorgestrel 1500 mcg ATC code: G03AD01
Manufacturer: Gedeon Richter Plc.
-
The medicine is a method of emergency contraception used in urgent situations, e.g., when no protection was used during intercourse or when a contraceptive method has failed (e.g., a condom broke).
Dosage form: tablets
Active substance Dosage levonorgestrel 1500 mcg ATC code: G03AD01
Manufacturer: Gedeon Richter Plc.
-
The medicinal product is a method of emergency contraception used in urgent situations, e.g., when unprotected sexual intercourse has occurred or when a contraceptive method has failed (e.g., a condom broke).
Dosage form: tablets
Active substance Dosage levonorgestrel 1500 mcg ATC code: G03AD01
Manufacturer: Gedeon Richter Plc.